374 related articles for article (PubMed ID: 35260039)
1. Utilization of HCV viremic donors in kidney transplantation: a chance or a threat?
Czarnecka P; Czarnecka K; Tronina O; Baczkowska T; Durlik M
Ren Fail; 2022 Dec; 44(1):434-449. PubMed ID: 35260039
[TBL] [Abstract][Full Text] [Related]
2. Transplantation of Kidneys From Hepatitis C Virus-Infected Donors to Hepatitis C Virus-Negative Recipients: One-Year Kidney Allograft Outcomes.
Molnar MZ; Azhar A; Tsujita M; Talwar M; Balaraman V; Bhalla A; Podila PSB; Kothadia J; Agbim UA; Maliakkal B; Satapathy SK; Kovesdy CP; Nair S; Eason JD
Am J Kidney Dis; 2021 May; 77(5):739-747.e1. PubMed ID: 33333148
[TBL] [Abstract][Full Text] [Related]
3. Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-positive Recipients in the Direct-acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?
Cannon RM; Locke JE; Orandi BJ; Anderson DJ; Davis EG; Mackelaite L; Dave H; Eng M; Jones CM
Transplantation; 2020 Jun; 104(6):1215-1228. PubMed ID: 31517783
[TBL] [Abstract][Full Text] [Related]
4. Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)-Viremic Donors Into HCV-Negative Recipients: Outcomes Following Liver Transplant of HCV-Viremic Donors.
Cotter TG; Paul S; Sandıkçı B; Couri T; Bodzin AS; Little EC; Sundaram V; Charlton M
Hepatology; 2019 Jun; 69(6):2381-2395. PubMed ID: 30706517
[TBL] [Abstract][Full Text] [Related]
5. Multicenter Study to Transplant Hepatitis C-Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus Infection.
Sise ME; Goldberg DS; Kort JJ; Schaubel DE; Alloway RR; Durand CM; Fontana RJ; Brown RS; Friedewald JJ; Prenner S; Landis JR; Fernando M; Phillips CC; Woodle ES; Rike-Shields A; Sherman KE; Elias N; Williams WW; Gustafson JL; Desai NM; Barnaba B; Norman SP; Doshi M; Sultan ST; Aull MJ; Levitsky J; Belshe DS; Chung RT; Reese PP
J Am Soc Nephrol; 2020 Nov; 31(11):2678-2687. PubMed ID: 32843477
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of kidney, liver, and simultaneous liver and kidney transplants from hepatitis c infected donors to hepatitis c naïve recipients: A large single center experience.
Elbeshbeshy H; Modi N; Patel T; Matthews I; Kampert T; Lee J; Okeke R; Caliskan Y; Fleetwood V; Varma C; Gabris B; Bastani B; Abu Al Rub F; Guenette A; Befeler A; Agbim U; Desai R; Alsabbagh E; Qureshi K; Schnitzler M; Lentine KL; Randall HB; Nazzal M
Clin Transplant; 2024 Jan; 38(1):e15161. PubMed ID: 37842872
[TBL] [Abstract][Full Text] [Related]
7. Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus-Infected Donors to Noninfected Recipients: An Open-Label Nonrandomized Trial.
Durand CM; Bowring MG; Brown DM; Chattergoon MA; Massaccesi G; Bair N; Wesson R; Reyad A; Naqvi FF; Ostrander D; Sugarman J; Segev DL; Sulkowski M; Desai NM
Ann Intern Med; 2018 Apr; 168(8):533-540. PubMed ID: 29507971
[TBL] [Abstract][Full Text] [Related]
8. Expanding the Deceased Donor Pool in Manitoba Using Hepatitis C-Viremic Donors: Program Report.
Cuvelier S; Van Caeseele P; Kadatz M; Peterson K; Sun S; Dodd N; Werestiuk K; Koulack J; Nickerson P; Ho J
Can J Kidney Health Dis; 2021; 8():20543581211033496. PubMed ID: 34367648
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C Virus NAT-Positive Solid Organ Allografts Transplanted Into Hepatitis C Virus-Negative Recipients: A Real-World Experience.
Kapila N; Menon KVN; Al-Khalloufi K; Vanatta JM; Murgas C; Reino D; Ebaid S; Shaw JJ; Agrawal N; Rhazouani S; Navas V; Sheffield C; Rahman AU; Castillo M; Lindenmeyer CC; Miller C; Quintini C; Zervos XB
Hepatology; 2020 Jul; 72(1):32-41. PubMed ID: 31659775
[TBL] [Abstract][Full Text] [Related]
10. Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor pool.
Dao A; Cuffy M; Kaiser TE; Loethen A; Cafardi J; Luckett K; Rike AH; Cardi M; Alloway RR; Govil A; Diwan T; Sherman KE; Shah SA; Woodle ES
Clin Transplant; 2019 Jul; 33(7):e13598. PubMed ID: 31104346
[TBL] [Abstract][Full Text] [Related]
11. Liver and Kidney Recipient Selection of Hepatitis C Virus Viremic Donors: Meeting Consensus Report From the 2019 Controversies in Transplantation.
Burton JR; Terrault NA; Goldberg DS; Bloom RD; Gilroy R; Heimbach JK; Brown RS; Everson GT; Rubin E; Wiesner R; Pomfret EA
Transplantation; 2020 Mar; 104(3):476-481. PubMed ID: 31634329
[TBL] [Abstract][Full Text] [Related]
12. Renal transplantation from seropositive hepatitis C virus donors to seronegative recipients in Spain: a prospective study.
Franco A; Moreso F; Merino E; Sancho A; Kanter J; Gimeno A; Balibrea N; Rodriguez M; Perez Contreras F
Transpl Int; 2019 Jul; 32(7):710-716. PubMed ID: 30773693
[TBL] [Abstract][Full Text] [Related]
13. Kidney Transplantation From Hepatitis C Virus-Infected Donors to Uninfected Recipients: A Systematic Review for the KDIGO 2022 Hepatitis C Clinical Practice Guideline Update.
Gordon CE; Adam GP; Jadoul M; Martin P; Balk EM
Am J Kidney Dis; 2023 Oct; 82(4):410-418. PubMed ID: 37061019
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of heart transplantation from hepatitis C virus-positive donors.
Aslam S; Yumul I; Mariski M; Pretorius V; Adler E
J Heart Lung Transplant; 2019 Dec; 38(12):1259-1267. PubMed ID: 31521479
[TBL] [Abstract][Full Text] [Related]
15. Utilization rates and clinical outcomes of hepatitis C positive donor hearts in the contemporary era.
Madan S; Patel SR; Rahgozar K; Saeed O; Murthy S; Vukelic S; Sims DB; Shin JJ; Goldstein DJ; Jorde UP
J Heart Lung Transplant; 2019 Sep; 38(9):907-917. PubMed ID: 31495408
[TBL] [Abstract][Full Text] [Related]
16. Trends in utilization of deceased donor kidneys based on hepatitis C virus status and impact of public health service labeling on discard.
Ariyamuthu VK; Sandikci B; AbdulRahim N; Hwang C; MacConmara MP; Parasuraman R; Atis A; Tanriover B
Transpl Infect Dis; 2020 Feb; 22(1):e13204. PubMed ID: 31677214
[TBL] [Abstract][Full Text] [Related]
17. Using HCV-viremic organs for lung transplantation does not confer higher rejection rates compared to HCV-negative organs.
Afshar K; Schonhoft E; Kozuch J; Kafi A; Yung G; Pollema T; Golts E; Aslam S
Clin Transplant; 2024 Feb; 38(2):e15260. PubMed ID: 38369851
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C-positive donor to negative recipient kidney transplantation: A real-world experience.
Jandovitz N; Nair V; Grodstein E; Molmenti E; Fahmy A; Abate M; Bhaskaran M; Teperman L
Transpl Infect Dis; 2021 Jun; 23(3):e13540. PubMed ID: 33259125
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of direct acting antiviral therapies in hepatitis C virus-negative liver transplant recipients of hepatitis C-viremic donors.
Snyder HS; Wiegel JJ; Khalil K; Summers BB; Tan T; Jonchhe S; Kaiser TE
Pharmacotherapy; 2022 Dec; 42(12):905-920. PubMed ID: 36373198
[TBL] [Abstract][Full Text] [Related]
20. Trends in Discard of Kidneys from Hepatitis C Viremic Donors in the United States.
Chang SH; Merzkani M; Lentine KL; Wang M; Axelrod DA; Anwar S; Schnitzler MA; Wellen J; Chapman WC; Alhamad T
Clin J Am Soc Nephrol; 2021 Feb; 16(2):251-261. PubMed ID: 33451990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
